Managing cannabis use in breastfeeding women

As more states legalize medicinal and recreational cannabis use and increasingly decriminalize cannabis, the risk to the growth and development of breastfeeding infants whose mothers use cannabis becomes a growing public health concern. The critical role that certified lactation consultants (CLCs) could play in postpartum management of cannabis use and a Call to Action to expand the role of CLCs […]

Continue reading »

Rates of depression and substance use higher for pregnant teens, study finds

Researchers from Lawson Health Research Institute and Brescia University College found that teenage pregnant women are more likely to live in poverty, have poorer mental health and have higher rates of substance use. There are limited Canadian studies on teenage pregnancies, in particular looking at risk factors and birth outcomes compared to women who became pregnant during adulthood. London researchers […]

Continue reading »

Nonmedical Rx opioid use in teens linked to parental use

(HealthDay)—Nonmedical prescription opioid (NMPO) use in adolescents is associated with parental NMPO use and with smoking and parent-adolescent conflict, according to a study published online Feb. 25 in Pediatrics. Pamela C. Griesler, Ph.D., from Columbia University in New York City, and colleagues examined the correlation between self-reported parental and adolescent lifetime NMPO use using data for 35,000 parent-child dyads with […]

Continue reading »

Adolescent cannabis use alters development of planning, self-control brain areas

Adolescent marijuana use may alter how neurons function in brain areas engaged in decision-making, planning and self-control, according to researchers at the University of Illinois at Chicago. The findings, which were presented at Neuroscience 2018, the annual meeting of the Society for Neuroscience, are the result of an animal model study focused on the structural development of the prefrontal cortex, […]

Continue reading »

Anti-inflammatory use during surgery could improve cancer outcomes

The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve their cancer outcome has been published in scientific journal, BMC Cancer. The research successfully tested an anti-inflammatory agent with anti-cancer properties known as Taurolidine in the SURGUVANT trial which was funded by a grant from Geistlich Pharma AG, Wolhusen, Switzerland. […]

Continue reading »
1 2 3